FilingReader Intelligence

Tiantan Bio to provide CNY 397m in subsidiary loans

May 27, 2025 at 05:11 PM UTCBy FilingReader AI

Beijing Tiantan Biological Products Corp (SSE:600161) will provide up to CNY 397 million in entrusted loans to four subsidiaries, including Kunming Blood Products, Guizhou Biologicals, Lanzhou Biologicals, and Shanghai Blood Products. These loans, facilitated through China National Pharmaceutical Group Finance Co (CNPG Finance), aim to support the subsidiaries' business development. The loans, with a one-year term, carry an interest rate benchmarked against China's one-year Loan Prime Rate (LPR).

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

News Alerts

Get instant email alerts when Beijing Tiantan Biological Products Corp publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →